- Home
- FAMI vs ALZN Comparison
FAMI vs ALZN Comparison
Compare FAMI & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FAMI
- ALZN
- Stock Information
- Founded
- FAMI 2015
- ALZN 2016
- Country
- FAMI China
- ALZN United States
- Employees
- FAMI N/A
- ALZN N/A
- Industry
- FAMI Packaged Foods
- ALZN Medicinal Chemicals and Botanical Products
- Sector
- FAMI Consumer Staples
- ALZN Health Care
- Exchange
- FAMI Nasdaq
- ALZN Nasdaq
- Market Cap
- FAMI 2.2M
- ALZN 2.6M
- IPO Year
- FAMI 2018
- ALZN 2021
- Fundamental
- Price
- FAMI $1.82
- ALZN $2.93
- Analyst Decision
- FAMI
- ALZN Strong Buy
- Analyst Count
- FAMI 0
- ALZN 1
- Target Price
- FAMI N/A
- ALZN $180.00
- AVG Volume (30 Days)
- FAMI 26.4K
- ALZN 711.6K
- Earning Date
- FAMI 08-08-2025
- ALZN 07-29-2025
- Dividend Yield
- FAMI N/A
- ALZN N/A
- EPS Growth
- FAMI N/A
- ALZN N/A
- EPS
- FAMI N/A
- ALZN N/A
- Revenue
- FAMI $64,131,332.00
- ALZN N/A
- Revenue This Year
- FAMI N/A
- ALZN $322.64
- Revenue Next Year
- FAMI N/A
- ALZN N/A
- P/E Ratio
- FAMI N/A
- ALZN N/A
- Revenue Growth
- FAMI N/A
- ALZN N/A
- 52 Week Low
- FAMI $1.43
- ALZN $2.75
- 52 Week High
- FAMI $8.26
- ALZN $135.54
- Technical
- Relative Strength Index (RSI)
- FAMI 50.59
- ALZN 36.96
- Support Level
- FAMI $1.74
- ALZN $2.75
- Resistance Level
- FAMI $1.94
- ALZN $3.07
- Average True Range (ATR)
- FAMI 0.12
- ALZN 0.19
- MACD
- FAMI -0.00
- ALZN 0.05
- Stochastic Oscillator
- FAMI 34.62
- ALZN 19.66
About FAMI Farmmi Inc.
Farmmi Inc is an investment holding company. Through its subsidiaries, it acts as a supplier of agricultural products. It is an agricultural technology enterprise focused on its supply chain platform by promoting edible mushroom products and agriculture technology. Its product offerings include tapioca, corn, red dates, shiitake mushrooms, mu er fungus, other edible fungi, and other agricultural products. Geographically, the company's products are sold in China, Southeast Asia, Japan, North America, Europe, and the Middle East under the Forasen and Farmmi brands.
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.